X

Health Care

Earnings Summary – Lupin Limited Reports 26.4% Revenue Growth in Third Quarter FY2026

Lupin Limited (NSE: LUPIN) is a global pharmaceutical company specializing in branded and generic formulations, biotechnology, and active pharmaceutical ingredients.…

ZIM Laboratories Q3FY26 profit rebounds on export-led growth; margins steady amid ongoing remediation and R&D push

ZIM Laboratories Limited (NSE:ZIMLAB), an India-based pharmaceutical formulations and nutraceutical company focused on oral thin films (OTF), innovative drug delivery…

Earnings Summary – Cohance Lifesciences Reports Q3 and Nine-Month Revenue and Profit Decline Amid Inventory Normalization

Cohance Lifesciences Limited (NSE: COHANCE) is a global contract research, development, and manufacturing organization focused on innovator partnerships. The company…

Divi’s Laboratories Reports Steady Q3 FY26 Growth Amid Labour Code Impact

Divi's Laboratories Limited (NSE: DIVISLAB), a leading Indian API manufacturer, posted consolidated total income of INR 2,692 crores for Q3…

Apollo Hospitals Delivers Strong Q3 FY26 Growth Amid Segment Diversification

Apollo Hospitals Enterprise Limited (NSE: APOLLOHOSP) announced robust Q3 FY26 results, showcasing 17% YoY consolidated revenue growth driven by healthcare…

Amanta Healthcare Limited reports steady Q3 FY26 growth; 9M profit rises on margin expansion and deleveraging

Amanta Healthcare Limited (NSE: AMANTA, BSE: 544502) reported steady revenue growth and improved profitability for the quarter and nine months…

India Pesticides Limited posts strong Q3 FY26 growth as exports and domestic demand lift earnings

India Pesticides Limited (NSE: IPL, BSE: 543311) reported strong growth in revenue and profit for the quarter ended Dec. 31,…

Supriya Lifescience Reports 11.2% Revenue Growth in Q3 FY26 Driven by Anesthetic Segment and Export Demand

Supriya Lifescience Limited (NSE: SUPRIYA) the active pharmaceutical ingredient manufacturer recorded increased top-line performance supported by higher capacity utilization and…

Aarti Pharmalabs Limited reports sequential margin recovery in Q3 FY26 as CDMO transit impact weighs on revenue

Aarti Pharmalabs Limited (NSE: AARTIPHARM, BSE: 543748) reported a sequential improvement in operating performance in the quarter ended Dec. 31,…

Healthcare Global Enterprises Limited Reports 13% Revenue Growth in Third Quarter FY26

HealthCare Global Enterprises Limited (NSE: HCG; BSE: 539787) India’s largest specialized cancer care provider, reported 13% revenue growth and 20%…